Dagmar P.
- Country
- Germany
- Department
- N/A
Research Overview
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
- Phase 2 Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of SAR444656 in Adults with Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 123 of 255 partner sites.
Specializations
Dermatological Research
This investigator specializes in the treatment of hidradenitis suppurativa, a chronic inflammatory skin condition. Their research focuses on evaluating novel therapeutic approaches for patients with moderate to severe disease manifestations.
- Inflammatory Skin Disorders
- Chronic Disease Management
- Advanced Therapeutics
The investigator's work encompasses assessment of innovative biological treatments targeting inflammatory pathways in dermatological conditions.
Clinical Efficacy Studies
Their expertise extends to evaluating the clinical effectiveness of novel biological agents in dermatology. The research particularly focuses on measuring therapeutic responses through standardized assessment methods.
- Treatment Response Evaluation
- Safety Assessment Protocols
- Long-term Disease Management
The investigator conducts comprehensive evaluations of treatment outcomes in inflammatory skin conditions.
Therapeutic Innovation
The investigator explores subcutaneous treatment modalities for chronic inflammatory conditions. Their work includes assessment of novel therapeutic agents for managing severe dermatological disorders.
- Biological Therapy Development
- Treatment Optimization
- Patient Response Monitoring
Their research contributes to advancing treatment options for patients with resistant skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.